Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Ambispective Observational Multicenter Registry of Patients With Uncontrolled Asthma in the Population of the Russian Federation

NCT06521229 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06521229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06521229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Ambispective Observational Multicenter Registry of Patients With Uncontrolled Asthma in the Population of the Russian Federation
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
June 27, 2024
Completion date
September 30, 2026
Enrollment
9,000 (estimated)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

uncontrolled asthma